Get the latest news, insights, and market updates on INN (Summit Hotel Properties, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2025 DIVIDENDS
Summit Hotel Properties, Inc. (NYSE: INN) (the "Company"), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the third quarter ended September 30, 2025, of $0.08 per share of common stock of the Company and per common unit of limited partnership interest in Summit Hotel OP, LP, the Company's operating partnership. The Company's third quarter common dividend represents an annualized dividend yield of 6.1 percent based on the closing pric Oct 31, 2025 - $INN
Innocan Pharma to Present at the 2025 ThinkEquity Conference
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that it will be participating in The ThinkEquity Conference, taking place October 30, 2025, at the Mandarin Oriental, New York City. Oct 24, 2025 - $INN
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its patent for LPT-CBD was allowed in Japan and will be officially granted upon completion of the administrative process. The patent covers a prolonged-release liposome-based formulation that encapsulates cannabinoids. Oct 15, 2025 - $INN
How Recent Analyst Shifts Are Changing the Story for Summit Hotel Properties
Summit Hotel Properties has experienced a slight decrease in its fair value estimate, dropping from $6.44 to $6.31 per share as industry analysts adjust their outlook for the stock. The minor reduction in its discount rate and tempered revenue growth projections highlight a cautious sentiment. At the same time, some positive sector trends provide grounds for optimism. Stay tuned as we explore how investors and analysts are tracking these developments to stay ahead of changing narratives in... Oct 6, 2025 - $INN
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce its ongoing collaboration with Freedom Farm, a sanctuary dedicated to rescuing animals that were expelled from the industrial farms as a result of the animals having physical disabilities and other medical conditions. Through this collaboration, Freedom Farm animals that suffer from painful conditions receive compassio Sep 18, 2025 - $INN
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its LPT-CBD poster presentation, delivered by Dr. Joseph V. Pergolizzi, Jr., MD, MBA, at the PAINWeek conference in Las Vegas, sparked genuine enthusiasm among conference participants. Sep 15, 2025 - $INN
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple